abstract |
The present disclosure relates to a method of determining a risk of developing breast cancer in a subject, the method comprising identifying whether at least 95 single nucleotide polymorphisms (SNPs) from Table A is present in a biological sample from the subject, wherein the presence of a risk allele of a SNP from Table A indicates that the subject has an increased risk of breast cancer, and wherein the presence of an alternative allele indicates that the subject has a decreased risk of breast cancer. |